News FDA Committee Backs Netarsudil, a Once-Daily Glaucoma Drug by Medscape • 2017/10/16 • 0 Comments The FDA advisory committee approved a new drug application for once-daily glaucoma drug netarsudil (Rhopressa), introducing a new drug class for this indication. Medscape Medical News Full Story →